Filing Details
- Accession Number:
- 0001477932-22-009480
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-21 16:00:25
- Reporting Period:
- 2022-12-19
- Accepted Time:
- 2022-12-21 16:00:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1474167 | Cosmos Health Inc. | COSM | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 270611758 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1660125 | Grigorios Siokas | 5 Ag. Georgiou Str., Pilea Thessaloniki J3 TK57001 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value | Acquisiton | 2022-12-19 | 260,870 | $11.50 | 1,130,774 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants | Acquisiton | 2022-12-19 | 260,870 | $11.50 | 260,870 | $11.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
260,870 | 2022-12-21 | 2027-12-21 | No | 4 | P | Direct |
Footnotes
- These shares were purchased by Mr. Siokas in a registered direct offering pursuant to the Company's "shelf" registration statement on Form S-3 (No. 333-267550) declared effective by the SEC on December 15, 2022.
- All share and per share amounts reflect a 1 for 25 reverse stock split effected on December 15, 2022 with the Secretary of State of Nevada.
- These warrants were purchased by Mr. Siokas in a private placement concurrent with the registered direct offering described in note (1) above.